AI: Post Collapse Recovery detected on 8 Sep 2026

C3.ai is forming a post-collapse recovery pattern at $10.46, positioned 36.2% above its 52-week low but still 48.3% below its 52-week high. The pattern shows solid structure (14.48/15) and volume support (12.0/12), though breakout conviction lags at 9.16/13. Key resistance sits at $11.82 with support at $8.30. The stock trades on elevated volume (1.32x average, 6.97M shares), MACD is turning positive (0.0202), and RSI at 55 indicates neutral momentum. The overall score of 68.64 reflects a mid-quality setup with 57.78% historical win probability, but beta of 1.32 suggests elevated volatility.

C3.ai released Q1 2027 earnings on September 2, 2026, just six days before this pattern detection. Revenue exceeded guidance at $52.4M with 50% gross margin improvement, and federal bookings surged 138% year-over-year driven by cost reductions and annualized savings of $135M. However, FY27 revenue is guided at $210–$240M, indicating structural headwinds. The company faces a class action lawsuit alleging materially false or misleading statements about growth prospects. According to 14 analysts, the average rating is "Sell" with a 12-month price target of $8.82, down 15.68% from current price. The pattern emerges as management attempts to rebuild credibility post-restructuring, but analyst consensus remains deeply skeptical.

A successful breakout above $11.82 resistance would target $11.19 conservatively—a modest 7% move from current price. Volume confirmation is critical; the pattern needs to sustain the elevated volume (>5.3M shares daily) through the breakout. Historical data suggests a 57.78% probability of success. Invalidation occurs at $8.30 support; failure to hold this level signals the recovery has stalled and downside risk toward $7-8 zone (consistent with analyst targets) materializes. The measured move is constrained, indicating limited upside if the pattern succeeds but defining clear downside risk.

14 analysts rate the stock "Sell" with $8.82 average target—21% below current price, directly conflicting with this recovery narrative. A class action lawsuit alleges false statements about growth and CEO health, creating legal overhang and reputational risk. FY2026 revenue collapsed 35.67% to $250M and losses doubled to $470.37M, evidencing structural business deterioration. With beta of 1.32 and volatility at 51%, sharp reversals are possible. Most critically, the conservative target of $11.19 leaves minimal margin for error—risk/reward is asymmetric with $2.89 downside to $8.30 support versus $0.73 upside to target.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.